Kiniksa Pharmaceuticals Appoints Ross Moat COO and Eben Tessari Chief Strategy Officer
I'm PortAI, I can summarize articles.
Kiniksa Pharmaceuticals International plc has appointed Ross Moat as Chief Operating Officer, effective January 10, 2026, overseeing commercial and functional operations. Eben Tessari has been named Chief Strategy Officer, responsible for strategic initiatives, business development, technical operations, and artificial intelligence. This announcement was published via EDGAR by the U.S. Securities and Exchange Commission.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments